zk1008295.htm


SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 
F O R M 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of May 2010
 
ELTEK LTD.
(Name of Registrant)
 
Sgoola Industrial Zone, Petach Tikva, Israel
(Address of Principal Executive Office)
 
    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F x Form 40-F o
 
    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
 
    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
 
    Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
 
Yes o No x
 
 
    If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ____________
 
This Form 6-K is being incorporated by reference into the Registrant’s Form S-8 Registration Statements File Nos. 333-12012 and 333-123559.
 
 
 

 
 
SIGNATURES
 
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
ELTEK LTD.
(Registrant)
 
       
 
By:
/s/ Amnon Shemer  
    Amnon Shemer  
   
Chief Financial Officer
 
       
 
Date: May 13, 2010
 
 
 

 
 
 
 Press Release
 
Eltek Reports Fourth Quarter and Year End
2009 Financial Results
 
PETACH-TIKVA, Israel, May 13, 2010 (NASDAQ:ELTK) - Eltek Ltd., the leading Israeli manufacturer of advanced flex-rigid circuitry solutions, announced today its financial results for the quarter and year ended December 31, 2009.
 
Fiscal year 2009:
 
Revenues for fiscal year 2009 were $36.4 million, a decrease of 16% compared to revenues of $43.1 million for 2008. The decrease in revenues is primarily attributable to the impact of the global economic slowdown.

Gross profit for fiscal year 2009 was $5.6 million (15% of revenues) compared with gross profit of $5.9 million (14% of revenues) in fiscal year 2008.  Gross profit margins increased despite the decrease in revenues, mainly due to cost-cutting measures the Company undertook, especially in payroll and raw material consumption, and the positive impact of the higher U.S. dollar exchange rate in 2009 compared to 2008

Operating loss for fiscal year 2009 was $456,000 compared with an operating loss of $1.6 million in 2008.
 
 
 

 
 

Net loss for fiscal year 2009 was $880,000 or ($0.13) per fully diluted share, compared with a net loss of $2.4 million or ($0.37) per fully diluted share in the 2008.
 
Fourth Quarter 2009:
 
Revenues for the fourth quarter ended December 31, 2009 were $9.0 million, similar to the revenues recorded in the fourth quarter of 2008. 

Gross profit for the fourth quarter of 2009 was $1.2 million (13% of revenues), compared with gross profit of $1.1 million (12% of revenues) in the fourth quarter of 2008.

Operating loss for the fourth quarter of 2009 was $542,000 compared with an operating loss of $1.1 million in the fourth quarter of 2008.

Net loss for the fourth quarter of 2009 was $729,000 or ($0.11) per fully diluted share, compared with a net loss of $1.3 million or ($0.2) per fully diluted share in the fourth quarter of 2008.

EBITDA:
 
In the fourth quarter ended December 31, 2009, Eltek had EBITDA of $14,000 compared with a negative EBITDA of $169,000 in the fourth quarter of 2008. Eltek’s EBITDA for the year ended December 31, 2009 was $1.6 million compared with EBITDA of $983,000 in 2008.
 
ELTEK uses EBITDA as a non-GAAP financial performance measurement. EBITDA is calculated by adding back to net income interest, taxes, depreciation and amortization. EBITDA is provided to investors to complement results provided in accordance with GAAP, as management believes the measure helps illustrate underlying operating trends in the Company's business and uses the measure to establish internal budgets and goals, manage the business and evaluate performance. EBITDA should not be considered in isolation or as a substitute for comparable measures calculated and presented in accordance with GAAP. Reconciliation between the company's results on a GAAP and non-GAAP basis is provided in a table immediately following the Consolidated Statement of Operations
 
 
 

 
 


Management Comments:
 
Arieh Reichart, President and Chief Executive Officer of Eltek commented: "Despite the global economic crisis that took a toll on our business during the past year as reflected in the 16% decline in our revenues, we are encouraged by the fact that our sales in the U.S. market, as well as in Italy and the Netherlands were not negatively influenced.  We continue to see sales opportunities in the U.S. military market with regard to the ITAR (International Traffic in Arms Regulations) approval we received in 2009 and expect it to contribute to additional new orders in 2010."
 
“In 2010, we continue with our cost reduction plan that we initiated in 2009, mainly through a reduction in the number of employees and a salary cut for our management team. We are implementing a manufacturing program which includes efficiency measures through eliminating activities that do not provide added value to our products, and improving production yield, in order to achieve profitability in 2010.” Mr. Reichart concluded.
 
Amnon Shemer, CFO of Eltek, added: “2009 presented Eltek with great challenges due to the global economic crisis. Nevertheless, we managed to reduce our net loss in the fourth quarter as well as in the fiscal year in 2009 compared to 2008, despite the 16% decline in revenues, mainly through cost reduction and improved manufacturing measures. Our bottom line loss is primarily attributable to the decrease in revenues in 2009 compared to 2008, which decline was partially offset by the increase in the dollar exchange rate compared with the Israeli Shekel, and the savings resulting from our cost reduction plan. "
 
 
 

 
 

About the Company
Eltek is Israel's leading manufacturer of printed circuit boards, the core circuitry of most electronic devices. It specializes in the complex high-end of PCB manufacturing, i.e., HDI, multilayered and flex-rigid boards. Eltek's technologically advanced circuitry solutions are used in today's increasingly sophisticated and compact electronic products. For more information, visit Eltek's web site at www.eltekglobal.com.
 
Forward Looking Statement:
 
Certain matters discussed in this news release are forward-looking statements that involve a number of risks and uncertainties including, but not limited to statements regarding expected results in future quarters, risks in product and technology development and rapid technological change, product demand, the impact of competitive products and pricing, market acceptance, the sales cycle, changing economic conditions and other risk factors detailed in the Company's Annual Report on Form 20-F and other filings with the United States Securities and Exchange Commission.
 
 
 

 
 
Eltek  ltd.
Unaudited Consolidated Statements of Operations
(In thousands US$, except per share data)

   
Three months ended
   
Year ended
 
   
December 31,
   
December 31,
 
   
2009
   
2008
   
2009
   
2008
 
                         
Revenues
    8,971       8,982       36,442       43,138  
Cost of revenues
    (7,802 )     (7,915 )     (30,882 )     (37,282 )
                                 
Gross profit
    1,169       1,067       5,560       5,856  
                                 
Research and development income, net
    0       0       0       100  
                                 
Selling, general and administrative expenses
    (1,711 )     (1,778 )     (6,016 )     (7,199 )
                                 
Impairment loss on goodwill
    0       (379 )     0       (379 )
                                 
Operating loss
    (542 )     (1,090 )     (456 )     (1,622 )
                                 
Financial expenses, net
    (165 )     (222 )     (424 )     (826 )
                                 
Other income, net
    0       0       4       1  
                                 
Loss before income tax expenses
    (707 )     (1,312 )     (876 )     (2,447 )
                                 
Income tax (expenses), net
    (5 )     0       (34 )     0  
                                 
Net loss
    (712 )     (1,312 )     (910 )     (2,447 )
                                 
Net profit (loss) attributable to non controlling interest
    (17 )     23       30       1  
                                 
Net loss attributable to Eltek Ltd.
    (729 )     (1,289 )     (880 )     (2,446 )
                                 
Earning per share
                               
                                 
Basic and diluted net loss per ordinary share
 attributable to Eltek Ltd. shareholders
    (0.11 )     (0.20 )     (0.13 )     (0.37 )
                                 
Weighted average number of ordinary shares used to
compute basic and diluted net loss per ordinary share
attributable to Eltek Ltd. shareholders (in thousands)
    6,610       6,610       6,610       6,610  
 
 
 

 
 
Eltek  ltd.
Unaudited Consolidated Balance Sheets
(In thousands US$)
   
December 31,
 
   
2009
   
2008
 
Assets
           
             
Current assets
           
Cash and cash equivalents
    1,258       1,556  
Receivables:   Trade, net of provision for doubtful accounts
    6,932       7,248  
Inventories
    3,938       4,429  
Prepaid expenses and other current assets
    463       410  
                 
Total current assets
    12,591       13,643  
                 
Assets held for employees' severance benefits
    1,432       1,166  
                 
Fixed assets, less accumulated depreciation
    9,175       10,090  
                 
Goodwill
    573       554  
                 
Total assets
    23,771       25,453  
                 
                 
Liabilities and Shareholder's equity
               
                 
Current liabilities
               
Short-term credit and current maturities of long-term debts
    5,638       5,898  
Accounts payable: Trade
    4,666       5,381  
                            Related parties
    713       561  
                            Other
    3,558       3,684  
                 
Total current liabilities
    14,575       15,524  
                 
Long-term liabilities
               
Long term debt, excluding current maturities
    2,617       2,607  
Employee severance benefits
    1,440       1,363  
                 
Total long-term liabilities
    4,057       3,970  
                 
Equity
               
Ordinary shares, NIS 0.6  par value authorized 50,000,000
shares, issued and outstanding 6,610,107 as of September 30,
2009, 6,610,107 as of September 30, 2008 and 6,610,107 as
of December 31, 2008
    1,384       1,384  
Additional paid-in capital
    14,328       14,328  
Cumulative translation adjustment related to change in reporting currency
    2,635       2,596  
Cumulative foreign currency translation adjustments
    309       268  
Capital reserve
    695       695  
Accumulated deficit
    (14,522 )     (13,642 )
Total Eltek Ltd. shareholders' equity
    4,829       5,629  
Non controlling interest
    310       330  
Total equity
    5,139       5,959  
Total liabilities and total equity
    23,771       25,453  
 
 
 

 
 
Non-GAAP EBITDA Reconcilliations
 
 
 
Three months ended
   
Year ended
 
   
December 31,
   
December 31,
 
   
2009
   
2008
   
2009
   
2008
 
   
Unaudited
 
                         
GAAP net loss
    (729 )     (1,289 )     (880 )     (2,446 )
Add back items:
                               
                                 
Financial  expenses, net
    165       222       424       826  
Tax expenses (income)
    5       0       34       0  
Impairment loss on goodwill
    0       379       0       379  
Depreciation
    573       519       2,030       2,224  
Adjusted EBITDA
    14       (169 )     1,608       983